Introduction
The research development connected with an antibody chip 1 is very important to realize more versatile protein chips 2, 3 for analyses of biomolecular recognition events in various biological signaling pathways and functions. 4 The detection of such recognition events with these chips is most popularly conducted by the direct-labeling of proteins with a fluorophore. [1] [2] [3] 5 This detection method permitted a highly sensitive one, but false positive signals were often obtained to cause a high background. 1 To avoid such a problem of the fluorescence-labeling method, quartz crystal microbalance (QCM) 6 or surface plasmon resonance (SPR) 7 measurements have been adopted, permitting non-labeling detection by using the mass change after biomolecular interactions, e.g., those of an antigen with the antibody chip. On the other hand, another type of non-labeling detection was recently realized by using Fourier transform infrared reflection-absorption spectroscopy (FT-IR RAS). 8 An excellent advantage of FT-IR RAS over QCM and SPR is that we can obtain structural information based on the chemical structure of target compounds. For example, we can detect the functional groups specific for biomolecules by FT-IR RAS: the amide, amino, carboxyl, etc. groups of proteins; the phosphate group of phosphoproteins and nucleic acids; the hydroxyl group of glycoproteins and saccharides.
In this paper, we present the preparation of an antibodyimmobilized chip using monoclonal antibody for the carcinoembryonic antigen (CEA) as an example. The immobilization of the antibody was achieved by a chemical reaction on a gold chip surface covered with a self-assembled monolayer (SAM) of 11-mercaptoundecanoic acid (MUA). The interaction of the antibody chip with CEA was analyzed by an FT-IR RAS 9 measurement. CEA is known to be one of the cancer makers, and can be used for a clinical diagnosis. 10 However, it is also known that CEA often gives a high rate of false positive signals. 11 When the FT-IR RAS measurement can be applied to this assay system, it should give a reduced rate of false positive signals because of its structural information. The concept of the immobilization of a CEA monoclonal antibody on a gold surface and its interaction assay with CEA are shown in Fig. 1 . The usefulness of the FT-IR RAS measurement has also been demonstrated in monitoring all manipulation steps (Fig. 1 ) of a gold chip surface.
Experimental

Materials
Gold-coated glass-plate chips were products of Tanaka Precious Metals (Japan). Gold substrates were prepared by the vacuum evaporation of titanium (50 nm thickness), followed by gold (80 nm thickness), onto the surface of a Pyrex glass plate (25.4 mm × 76.2 mm × 1.4 mm). Mouse CEA monoclonal antibody was purchased from Sigma (USA). CEA and CEA polyclonal antibodies were obtained as components of a CEA Enzyme Immunoassay Kit (Hope Laboratories, Inc., USA). Other chemicals used were of the highest grade available. Water was purified by a Milli-Q system Gradient A10 coupled with Elix 3 Kit (Millipore, USA).
It is reported that the formation of SAM on the gold surface is affected by the conditions of the gold crystal face, and that sulfur atoms tightly bind to Au(111). 12 A concentrated X-ray diffraction (XRD) measurement of the fabricated gold chip surface showed the main peak at a diffraction of d = 2.354 Å or a diffraction angle of 2θ = 38.21˚, which corresponds to A monoclonal antibody for the carcinoembryonic antigen (CEA) was immobilized on a gold chip surface covered by a self-assembled monolayer of 11-mercaptoundecanoic acid. Upon the addition of CEA, a Fourier transform infrared reflection-absorption spectroscopy (FT-IR RAS) measurement showed an increased absorption at around 1500 -1700 cm -1 , corresponding to its amide structures. Another addition of CEA polyclonal antibody on this chip caused a further increase of the absorption in this region only after a treatment with CEA. This result shows that an antibody-fixed gold surface coupled with an FT-IR RAS measurement provides a new tool for detecting the antibody-antigen interaction.
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Au (111); the ratio of the Au(111) face to the total gold surface was calculated to be ca. 88%. X-ray data were obtained from Tanaka Precious Metals.
FT-IR RAS measurement
An FT-IR RAS measurement was performed on a Perkin Elmer Spectrum One FT-IR spectrometer equipped with a Refractor 2 TM (Harrick Scientific Inc.) with a single Brewster's angle silicon polarizer plate (grazing angle, 75˚), and a liquidnitrogen cooled mercury cadmium telluride detector (Perkin Elmer). The spectra were taken by adding approximately 1000 scans at a resolution of 4 cm -1 , which were referenced to the spectrum of a bare gold substrate. All measurements were performed at room temperature under dried air.
Preparation of an antibody-immobilized gold substrate
The immobilization steps of monoclonal antibody for the CEA on the gold chip surface are illustrated in Figs. 1a -c. Firstly, the gold-coated chip was soaked in a piranha solution (3:1 mixture of concentrated sulfuric acid and 30% hydrogen peroxide) for 5 min (CAUTION: the piranha solution reacts violently with many organic materials and should be handled with great care), then washed with water, and dried with a spin dryer. Secondly, the plate was soaked overnight in 20 ml of 10 mM MUA in ethanol to form SAM, followed by washing with water. The plate was dried, and an FT-IR RAS measurement was carried out (Fig. 2a) . The chip was then soaked in an aqueous 1:1 mixture (20 ml) of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) (100 mg ml -1 ) and N-hydroxysuccinimide (NHS) (100 mg ml -1 ) for 30 min to activate the carboxylic acid-terminated SAM, washed with water, and dried. Then, an FT-IR RAS measurement was performed (Fig. 2b) . After that, 500 µl of a CEA monoclonal antibody solution (0.1 mg ml -1 ) in 1 mM potassium 4-(2-hydroxyethyl)-1-piperazineethanesulufonate (HEPES-KOH) buffer (pH 8.0) was placed on the gold chip surface, and incubated overnight at 5˚C (Fig. 1c) . After gentle washing with water, the gold chip surface was dried with a spin dryer, and analyzed by FT-IR RAS (Fig. 3A, a) . All steps were carried out at room temperature, except when otherwise noted.
CEA antibody-CEA interaction
A 500 µl solution of CEA (1.0 mg ml -1 ) in a phosphate buffered saline (PBS) (1.47 mM KH2PO4, 8.1 mM Na2HPO4, 2.68 mM KCl, 1.37 mM NaCl; pH 7.4) buffer or 500 µl of PBS buffer (pH 7.4) (as a negative control) was placed on the CEA monoclonal antibody-immobilized substrate, and incubated for 1 h (see Fig. 1d ), washed with water and dried; an FT-IR RAS measurement was then carried out. Subsequently, the resulting chip was immersed into a 500 µl solution of CEA polyclonal antibody, and incubated for 1 h. After gentle washing with water and drying with a spin dryer, an FT-IR measurement was carried out again. The same experiment without a CEA treatment was also performed to verify the specificity of the interaction. All steps were carried out at room temperature.
Results and Discussion
Chemical immobilization of a CEA antibody on a gold substrate and analysis by an FT-IR RAS measurement
There have been many reports on the immobilization of proteins on a gold surface. However, very few detailed studies have been reported concerning the process of the protein immobilization occurring on the gold surface. Thus, to gain more detailed structural information on this process, we were interested in using FT-IR RAS for monitoring the immobilization process on a gold surface and the subsequent interaction process of the protein-immobilized gold surface with other proteins. Therefore, we attempted to carry out an FT-IR RAS analysis of each step shown in Fig. 1 .
Firstly, the SAM formation step (Fig. 1a) on a gold surface with MUA was analyzed by an FT-IR RAS measurement. As shown in Fig. 2a , the spectrum showed a characteristic band at 1740 cm -1 corresponding to a υ(C=O) free carboxylic acid stretch and a small shoulder at around 1720 cm -1 were assigned as a υs(C=O) H-bonded carboxylic acid stretch, which had already been assigned by Frey and Corn 13 using SAM of MUA on a gold substrate. This result indicated the formation of SAM of MUA on the gold surface.
Secondly, an activation step (Fig. 1b) of the terminus carboxyl group of MUA-SAM by EDC and NHS was examined. The obtained spectrum (Fig. 2b) ester of MUA on the gold surface, because the observed bands at 1818 cm -1 , 1791 cm -1 , and 1745 cm -1 belong to the υ(C=O) carbonyl stretch of NHS ester of MUA, the υs(C=O) symmetric stretch of the NHS carbonyls, and the υas(C=O) asymmetric stretch of the NHS carbonyls, respectively. 13 Then, an immobilization step (Fig. 1c) of CEA monoclonal antibody via the reaction of the NHS active ester with its amino groups on the gold surface was analyzed by an FT-IR RAS measurement, while focusing on the absorption at around 1500 -1700 cm -1 , corresponding to the protein amide bond. The obtained spectrum showed strong absorption bands at around the 1600 -1700 cm -1 region and the 1500 -1600 cm -1 region belonging to protein-specific amide bonds of amide I and amide II, respectively, and no band at 1745 cm -1 belonging to the υas(C=O) asymmetric stretch of the NHS carbonyls of the active ester. 8, 13 ( Fig. 3A, a) . These results clearly showed that the protein-immobilization step and the disappearance of the active ester moiety of MUA on the gold substrate could be monitored by an FT-IR RAS measurement. To avoid any further reaction of the residual NHS ester after protein-immobilization, usually inactivation of the active ester is necessary with adequate reagents, such as 2-aminoethanol. However, such a treatment with 2-aminoethanol was not needed in our case, as described above.
Detection of CEA by using FT-IR RAS
CEA is one of the most widely used tumor markers, and CEA measurements are carried out as daily work in clinical fields using a dual-antibody sandwich-type assay method. 11, 14 We firstly tried to detect human CEA without using a second antibody. Human CEA was subjected to the CEA monoclonal antibody-immobilized gold surface (Fig. 1d) and analyzed by FT-IR RAS. A comparison of the spectra obtained before and after the interaction with CEA revealed an increase of the absorption at around 1500 -1700 cm -1 , corresponding to the amide bond after a CEA treatment (Fig. 3A) . This experiment was repeated several times using differently prepared gold substrates under the same conditions. The differential FT-IR RAS spectra obtained by subtracting the spectra after CEA treatment from those before CEA treatment were reproducible, as shown in Fig. 3B . This result shows that the CEA monoclonal antibody-fixed gold chip surface can be used for the detection of CEA by FT-IR RAS with excellent reproducibility.
To confirm that the absorption enhancement of the amide bond was not the result of non-specific binding of CEA to the gold substrate, we added a CEA polyclonal antibody as a second antibody to the CEA monoclonal antibody-fixed substrate (Fig. 4a) after treating with CEA (Fig. 4c) , or without CEA (Fig. 4b) ; FT-IR RAS was then measured. Since CEA polyclonal antibody has different CEA recognition sites from the monoclonal one, a sandwich-type interaction might be expected, as shown in Fig. 4c . The absorption enhancement was observed only after the addition of CEA (Fig. 5c) to the CEA monoclonal antibody-fixed gold surface (Fig. 5a ), whereas no enhancement occurred after a direct interaction of the second antibody without CEA (Fig. 5b) , suggesting that the species that bound to the first antibody-fixed gold substrate was CEA.
Estimation of the detection limit in this assay system
When CEA antibody was assumed to be a globular protein with a dimmer of 10 nm, 15 the coverage area by one CEA antibody molecule was calculated to be 25 × 3.14 × 10 -14 cm 2 . The actual area in the FT-IR RAS measurement was 3 cm 2 and a rough calculation using Avogadro's number gave 4 × 10 12 molecules or ca. 1 pmol of CEA antibody on this gold surface. In other words, less than 1 pmol of CEA could be detected by this measurement. However, immobilized antibodies on solid supports often display heterogeneous binding affinities after immobilization, e.g., the affinity values are ca. 1 order of magnitude smaller than the corresponding affinities in solution. 16, 17 Thus, the actual amount of the effective CEA antibody on the gold surface having a proper orientation to react with CEA should be ca. 1/10 of the total amount of the antibody fixed on this surface. Therefore, the detectable CEA should be 217 ANALYTICAL SCIENCES MARCH 2005, VOL. 21 Fig. 2 FT-IR RAS spectra of a gold substrate at steps of (a) and (b) in Fig. 1 . Fig. 3 (A) FT-IR RAS spectra of CEA monoclonal antibody-fixed to a gold surface before (a) and after (b) a treatment with CEA. (B) Differential FT-IR RAS spectra of three different gold chips covalently fixed with a CEA monoclonal antibody, which were obtained by subtracting the spectra after CEA treatment from those before CEA treatment. Fig. 4 Schematic illustration of the evaluation of the non-specific adsorption of CEA. FT-IR RAS measurements of a CEA monoclonal antibody-fixed gold chip (a) with (c) or without a CEA pretreatment (b) were carried out after a treatment of CEA polyclonal antibody. The gold substrate of (a) is exactly the same one as that of (c) in Fig. 1. 0.1 pmol on this gold surface. Considering the peak intensity of the amide I band at 1665 cm -1 in Fig. 3A , at least ca. 1/10 of the intensity can be discriminated from the background. Thus, the detection limit in this assay system will be at the 0.01 pmol level.
Conclusion
We demonstrated the usefulness of the FT-IR RAS measurement for monitoring the manipulation processes of protein chips and the subsequent interaction with target molecules. As an example, we selected an antibody for CEA as the protein to be immobilized on the chip surface. Thus, by using FT-IR RAS, we could successfully monitor the immobilization steps of monoclonal antibody for CEA on a gold chip surface covered by SAM of MUA. Further observation of the interaction of this chip with the target molecule, CEA, by FT-IR RAS provided an increased absorption around 1500 -1700 cm -1 specific for the protein amide bond. Another addition of CEA polyclonal antibody on the chip additionally increased the amide bond-specific absorption only after a treatment with CEA, indicating that this assay method is advantageous for CEA detection. Thus, the FT-IR RAS measurement will provide a new analytical tool for monitoring the fabrication processes of an antibody chip and its interaction process with an antigen. The combination of this FT-IR RAS and another non-labeling detection method, such as QCM or SPR, will enable us to obtain more detailed chemical information on the chip surface conditions during the preparation of bio-chips and their interaction with target biomolecules.
